American Diabetes Association
Browse

Effectiveness of non-mydriatic ultra-widefield retinal imaging to screen for diabetic eye disease: a randomized controlled trial (Clearsight)

Download (413.41 kB)
figure
posted on 2022-12-05, 16:21 authored by Selina L. Liu, John R. Gonder, Ehsan Owrangi, Neil S. Klar, Irene M. Hramiak, Artem Uvarov, Jeffrey L. Mahon

  

Objective

Suboptimal diabetic eye disease screening is a major cause of preventable vision loss. Screening barriers include mydriasis and need for dedicated screening appointments. The Clearsight trial assessed whether non-mydriatic ultra-widefield (NM UWF) screening on the day of a diabetes clinic visit improved detection of clinically important eye disease vs usual screening.

Research Design and Methods 

This single-center, randomized, parallel-group controlled trial was conducted at St. Joseph’s Health Care, London, Canada. Adults with diabetes due for screening were randomized to same-day On-Site Screening (NM UWF imaging) on the day of a scheduled diabetes clinic visit or Usual Screening (encouraged to arrange optometrist screening). The primary outcome was detection of actionable eye disease (AED) defined as need for ophthalmology referral or increased ocular surveillance. The primary analysis (modified intention-to-screen) compared the proportions of AED between groups within one year of enrollment. 

Results 

Of 740 participants randomized between March 7, 2016 and April 17, 2019, 335 On-Site Screening and 323 Usual Screening participants met criteria for the primary analysis. More AED was detected in the On-Site Screening than Usual Screening groups (50/335 [14.9%] vs 22/323 [6.8%]; adjusted odds ratio 2.51 [95% CI 1.49–4.36]). The number-needed-to-screen by On-Site Screening to detect one additional patient with AED was 13 [95% CI 8–29].

Conclusions 

Same-day On-Site Screening by NM UWF imaging increased detection of clinically important diabetic eye disease vs Usual Screening. Integration of NM UWF imaging into routine diabetes clinic visits improved screening adherence and has the potential to prevent vision loss.

Funding

Physicians' Services Incorporated Foundation 15-20

History

Usage metrics

    Diabetes Care

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC